SPIRIVA RESPIMAT TIOTROPIUM 0.226/1ML 4ML & DEVICE

Description

COPD: SPIRIVA® in its RESPIMAT® Dosing Device is indicated for maintenance therapy of patients with Chronic Obstructive Pulmonary Disease (COPD) (including chronic bronchitis and emphysema), maintenance therapy of associated dyspnea, improvement of the quality of life compromised by COPD and for the reduction of exacerbations.

ASTHMA: SPIRIVA® in its RESPIMAT® Dosing Device is indicated as additional maintenance bronchodilator treatment in patients 6 years of age and older with asthma who remain symptomatic despite treatment with at least corticosteroids for symptom improvement and reduction of exacerbations.